dr. wakelee on explaining adjuvant therapy benefits to patients
Published 12 years ago • 136 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:05
dr. wakelee discusses adjuvant therapy predictive markers
-
1:52
dr. wakelee discusses adjuvant therapy in elderly nsclc patients
-
1:13
dr. wakelee discusses the future of lung cancer adjuvant therapy
-
17:16
gracecast-028_lung-cancer_heather wakelee on nsclc adjuvant therapy
-
5:23
adjuvant therapy for stage ii and iii colon cancer
-
2:58
adjuvant versus neoadjuvant chemotherapy for nsclc
-
2:03
dr. wakelee on rationale to explore osimertinib with concurrent chemotherapy in egfr-mutant nsclc
-
6:51
key takeaway 1: adjuvant therapy optimal duration
-
9:24
impower010 supports adjuvant atezolizumab in early-stage nsclc | heather wakelee
-
0:59
dr. weksler on neoadjuvant and adjuvant therapy in nsclc
-
1:23
dr. wakelee discusses current state of treatment in nsclc
-
11:13
patient selection for adjuvant therapy in ebc
-
13:18
managing adjuvant treatment in colorectal cancer, part ii
-
9:54
idea trial: 3 vs 6 months of adjuvant therapy in crc
-
1:19
dr. wakelee on combining targeted agents for the treatment of lung cancer
-
3:31
adjuvant therapy explained
-
1:59
gracecastuc-026_lung_dr. wakelee on using molecular marker info for mgmt. of earlier stage nsclc
-
1:01
dr. o’neil on adjuvant therapy in bladder cancer
-
1:50
gracecastuc-065_lung_dr. wakelee on most promising new agents and pathways for treating lung cancer